Verfasser Suchresultate

Normdaten (Quelle GND / Entity Facts )

Mike Wenzel

geboren 1991
Urologe, Arzt

Affiliation
Klinik für Urologie und Kinderurologie (Frankfurt am Main)

Wirkungsort
Frankfurt am Main

Varianten
M. Wenzel

Weiterführende Links

Gemeinsame Normdatei (GND) im Katalog der Deutschen Nationalbibliothek

Open Researcher and Contributor ID (ORCID)

Deutsche Digitale Bibliothek

Virtual International Authority File (VIAF)

Wikidata

Association between frailty and specific comorbidities on oncological outcomes in metastatic hormone-sensitive and castration resistant prostate cancer

Wenzel, Mike (Verfasser)

Urologic oncology. - Amsterdam : Elsevier, 2025. - Seite 9-16. - 10.1016/j.urolonc.2025.01.001. - ISSN 1078-1439. - Jahrgang 43, Heft 6, Artikel 397

E-Book

Prostate-specific antigen nadir and cancer-control ouutcomes in real-world apalutamide-treated metastatic hormone-sensitive prostate cancer patients: a single-center analysis

Wenzel, Mike (Verfasser)

European urology oncology. - Amsterdam : Elsevier, 31.08.2024. - Seite 364-371. - 10.1016/j.euo.2024.08.007. - ISSN 2588-9311. - Jahrgang 8, Heft 2

E-Book

Contemporary treatment patterns and oncological outcomes of metastatic hormone-sensitive prostate cancer and first- to sixth- line metastatic castration-resistant prostate cancer patients

Wenzel, Mike (Verfasser)

European urology open science. - Amsterdam : Elsevier, 27.06.2024. - Seite 46-54. - 10.1016/j.euros.2024.06.010. - ISSN 2666-1683. - Jahrgang 66

E-Book

Assessment of different castration resistance definitions and staging modalities in metastatic castration-resistant prostate cancer

Wenzel, Mike (Verfasser)

Cancers. - Basel : MDPI, 17.10.2024. - 10.3390/cancers16203506. - ISSN 2072-6694. - Jahrgang 16, Heft 20, Artikel 3506

E-Book

Influence of tumor characteristics and time to metastatic disease on oncological outcomes in metachronous metastatic prostate cancer patients

Wenzel, Mike (Verfasser)

Clinical genitourinary cancer. - Amsterdam : Elsevier, 10.07.2024. - 10.1016/j.clgc.2024.102158. - ISSN 1558-7673. - Jahrgang 22, Heft 5, Artikel 102158

E-Book

Prostate-specific antigen nadir and cancer-control ouutcomes in real-world a

Wenzel, Mike (Verfasser)

European urology oncology. - Amsterdam : Elsevier, 31.08.2024. - 10.1016/j.euo.2024.08.007. - ISSN 2588-9311. - Jahrgang 2024

E-Book

Androgen receptor pathway inhibitors vs. docetaxel chemotherapy for metastatic hormone-sensitive and first-line castration resistant prostate cancer

Wenzel, Mike (Verfasser)

World journal of urology. - Berlin ; Heidelberg : Springer, 28.12.2024. - Seite 1-7. - 10.1007/s00345-024-05388-1. - ISSN 1433-8726. - Jahrgang 43, Artikel 51

E-Book

Influence of metastatic sites and burden on oncological outcomes in patients progressing to metastatic castration resistant prostate cancer

Wenzel, Mike (Verfasser)

World journal of urology. - Berlin ; Heidelberg : Springer, 02.11.2024. - Seite 1-7. - 10.1007/s00345-024-05341-2. - ISSN 1433-8726. - Jahrgang 42, Artikel 615

E-Book

Treatment patterns and oncological outcomes of older adults with metastatic prostate cancer in real-world setting

Wenzel, Mike (Verfasser)

Journal of the American Geriatrics Society. - Oxford : Wiley-Blackwell, 26.06.2024. - Seite 2700-2708. - 10.1111/jgs.19045$5. - Jahrgang 72, Heft 9

E-Book

Correction: Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis

Wenzel, Mike (Verfasser)

Prostate Cancer and Prostatic Diseases. - Basingstoke : Stockton Press, 10.03.2023. - Seite 1-2. - 10.1038/s41391-023-00656-4. - ISSN 1476-5608. - Jahrgang 26

E-Book

Real-world evidence of outcomes of oligometastatic hormone-sensitive prostate cancer patients treated with metastasis-directed therapy

Wenzel, Mike (Verfasser)

The prostate. - New York, NY : Wiley-Liss, 18.07.2023. - Seite 1365-1372. - 10.1002/pros.24599. - ISSN 1097-0045. - Jahrgang 83, Heft 14

E-Book

The effect of race/ethnicity on cancer-specific mortality after salvage radical prostatectomy

Wenzel, Mike (Verfasser)

Frontiers in oncology. - Lausanne : Frontiers Media, 19.08.2022. - Seite 1-9. - 10.3389/fonc.2022.874945. - ISSN 2234-943X. - Jahrgang 12, Artikel 874945

E-Book

An external validation of the nocera nomogram: Predicting non-organ confined stage of ≥pT3 in cT1 clear cell renal cell carcinoma

Wenzel, Mike (Verfasser)

Frontiers in oncology. - Lausanne : Frontiers Media, 10.10.2022. - Seite 1-9. - 10.3389/fonc.2022.1019057. - ISSN 2234-943X. - Jahrgang 12, Artikel 1019057

E-Book

Editorial Comment to Testicular cancer and YouTube: What do you expect from a social media platform?

Wenzel, Mike (Verfasser)

International journal of urology. - Oxford : Wiley-Blackwell, 31.03.2022. - Seite 691-691. - 10.1111/iju.14886. - ISSN 1442-2042. - Jahrgang 29, Heft 7

E-Book

Survival rates with external beam radiation therapy in newly diagnosed elderly metastatic prostate cancer patients

Wenzel, Mike (Verfasser)

The prostate. - New York, NY : Wiley-Liss, 11.10.2021. - Seite 78-85. - 10.1002/pros.24249. - ISSN 1097-0045. - Jahrgang 82, Heft 1

E-Book

Incidence rates and contemporary trends in primary urethral cancer

Wenzel, Mike (Verfasser)

Cancer Causes & Control. - Dordrecht : Springer Science + Business Media B.V., 22.03.2021. - Seite 627-634. - 10.1007/s10552-021-01416-2. - ISSN 1573-7225. - Jahrgang 32, Heft 6

E-Book

Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis

Wenzel, Mike (Verfasser)

Prostate Cancer and Prostatic Diseases. - Basingstoke : Stockton Press, 30.05.2021. - Seite 139-148. - 10.1038/s41391-021-00395-4. - ISSN 1476-5608. - Jahrgang 25, Heft 2

E-Book

Urologische Prostatakrebsvorsorge im Rahmen der Movember-Gesundheitsinitiative 2019 am Universitätsklinikum Frankfurt

Wenzel, Mike (Verfasser)

Der Urologe. - [Berlin ; Heidelberg ; New York] : Springer Medizin, 02.07.2020. - Seite 1237-1245. - 10.1007/s00120-020-01265-y. - ISSN 1433-0563. - Jahrgang 59, Heft 10

E-Book